BioMedNewsBreaks – Spok Holdings Inc. (NASDAQ: SPOK) to Present at Inaugural EF Hutton Global Conference

Spok Holdings (NASDAQ: SPOK) yesterday announced that Vincent D. Kelly, its president and chief executive officer, will be presenting at the Inaugural EF Hutton Global Conference. The two day, invitation-only event will be held on May 10-11, 2023, at the Plaza Hotel in the heart of New York City. The Inaugural conference will feature key executives from approximately 150 public and private companies to convey their unique stories to an extensive audience that includes institutional investors, high-net worth individuals, corporate clients and exclusive members of the press.

To view the full press release, visit https://ibn.fm/UCwAa

About Spok Inc.

Spok, a wholly owned subsidiary of Spok Holdings Inc., headquartered in Alexandria, Virginia, is proud to be a global leader in healthcare communications. The company delivers clinical information to care teams when and where it matters most to improve patient outcomes. Top hospitals rely on the Spok Care Connect(R) platform to enhance workflows for clinicians and support administrative compliance. Its customers send over 100 million messages each month through their Spok(R) solutions. Spok enables smarter, faster clinical communication. For more information, visit spok.com or follow @spoktweets on Twitter.

About BioMedWire

BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information please visit https://www.biomedwire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork

Chris@BMW

Share
Published by
Chris@BMW

Recent Posts

BioMedNewsBreaks — NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Report Q1 2025 Results on May 15 

NRx Pharmaceuticals (NASDAQ: NRXP) announced it will release its first quarter 2025 financial results after…

9 hours ago

BioMedNewsBreaks — Calidi Biotherapeutics Inc. (NYSE American: CLDI) Eyes Game-Changing Approach to Cancer Treatment

Calidi Biotherapeutics (NYSE American: CLDI) recently announced promising preclinical results for its innovative RTNova platform, which…

3 days ago

BioMedNewsBreaks — Adageis’ AI-Powered Platform Empowers Smarter Billing, Better Care

Adageis, a healthcare technology company, is transforming how providers manage insurance payments with its AI-driven…

4 days ago

BioMedNewsBreaks — Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Reports $4.8 Million Net Gain in 2024, Driven by Loan-to-Equity Conversion 

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharma company focused on inflammation and immunology treatments and CDMO services,…

4 days ago

BioMedNewsBreaks — Soligenix Inc. (SNGX) CEO Highlights Pipeline and Strategy in Latest BioMedWire Podcast Episode

Soligenix (SNGX) Chairman and CEO Dr. Christopher Schaber joined IBN’s BioMedWire Podcast to discuss the…

5 days ago

BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Adds Two U.S. Patents to Bolster Cardiac Monitoring IP Portfolio 

HeartBeam (NASDAQ: BEAT), a medical technology company advancing personalized cardiac care, announced the issuance of…

6 days ago